Is there a benefit to early angiography in patients with ST-segment depression myocardial infarction? An observational study

American Heart Journal

Volumn 143, Issue 3, 2002, Pages 488-496

  Shavelle, David M ^a   Parsons, Lori ^a   Sada, Mark J ^b   French, William J ^b   Every, Nathan R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b St John's Cardiovascular Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ST SEGMENT DEPRESSION; SURVIVAL TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0036185364     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.120970     Document Type: Article

References (25)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
2. Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction
3. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
4. The outcome of patients with a first non-Q wave myocardial infarction presenting with ST segment depression, ST segment elevation, or no ST deviations on the admission electrocardiogram
5. One-year results of The Thrombolysis in Myocardial Infarction [TIMI) IIIB clinical trial: A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave Myocardial Infarction
6. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
7. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study
8. Variations between countries in invasive cardiac procedures and outcome in patients with suspected unstable angina or myocardial infarction without initial ST elevation
9. Invasive versus conservative strategies in unstable angina and non-Q wave myocardial infarction following treatment with tirofiban: Rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thombolysis in Myocardial Infarction
10. The central role of the propensity score inobservational studies for causal effect
11. The effectiveness of right heart catheterization in the initial care of critically ill patients
12. Aspirin, heparin, or both to treat acute unstable angina
13. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
14. Diltiazem and reinfarction in patients with non-Q wave myocardial infarction
15. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
16. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
17. Effects of tissue plasminogen activator and a 1212 comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial
18. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: Results of the medicine versus Angiography in Thrombolytic Exclusion (MATE) Trial
19. Early statin treatment following acute myocardial infarction and 1-year survival
20. Propensity score
21. Risk stratification of patients with non-Q-wave myocardial infarction. The critical role of ST-segment depression. The Diltiazem Reinfarction Study Research group
22. Comparison of short and long term prognosis in patients with anterior wall versus inferior or lateral wall non-Q wave myocardial infarction: Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group
23. Differential risk patterns associated with 3 month as compared with 3 to 12 month mortality and reinfarction after non-Q wave myocardial infarction